blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3755351

EP3755351 - COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.11.2020
Database last updated on 03.06.2024
FormerThe international publication has been made
Status updated on  31.08.2019
Most recent event   Tooltip26.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Entrada Therapeutics, Inc.
One Design Center Place
Suite 17-500
Boston, MA 02210 / US
[2023/32]
Former [2021/01]For all designated states
Entrada Therapeutics, Inc.
28 State Street, Suite 2303
Boston, MA 02109 / US
Inventor(s)01 / SETHURAMAN, Natarajan
c/o ENTRADA THERAPEUTICS INC.
50 Northern Avenue
Boston, MA 02210 / US
02 / RUTH, Jason
c/o ENTRADA THERAPEUTICS INC.
50 Northern Avenue
Boston, MA 02210 / US
03 / TARTAGLIA, Lou
c/o ENTRADA THERAPEUTICS INC.
50 Northern Avenue
Boston, MA 02210 / US
04 / PEI, Dehua
c/o ENTRADA THERAPEUTICS INC.
50 Northern Avenue
Boston, MA02210 / US
05 / QIAN, Ziqing
c/o ENTRADA THERAPEUTICS INC.
50 Northern Avenue
Boston, MA 02210 / US
 [2021/01]
Former [2021/01]01 / SETHURAMAN, Natarajan
c/o ENTRADA THERAPEUTICS, INC. 28 State Street
Suite 2303
Boston, Massachusetts 02109 / US
02 / RUTH, Jason
c/o ENTRADA THERAPEUTICS, INC. 28 State Street
Suite 2303
Boston, Massachusetts 02109 / US
03 / TARTAGLIA, Lou
c/o ENTRADA THERAPEUTICS, INC. 28 State Street
Suite 2303
Boston, Massachusetts 02109 / US
04 / PEI, Dehua
c/o ENTRADA THERAPEUTICS, INC. 28 State Street
Suite 2303
Boston, Massachusetts 02109 / US
05 / QIAN, Ziqing
c/o ENTRADA THERAPEUTICS, INC. 28 State Street
Suite 2303
Boston, Massachusetts 02109 / US
Representative(s)Secerna LLP
The Old Fire Station
18 Clifford Street
York YO1 9RD / GB
[N/P]
Former [2021/01]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date19758042.622.02.2019
[2021/01]
WO2019US19117
Priority number, dateUS201862633933P22.02.2018         Original published format: US 201862633933 P
US201962796823P25.01.2019         Original published format: US 201962796823 P
[2021/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019165183
Date:29.08.2019
Language:EN
[2019/35]
Type: A1 Application with search report 
No.:EP3755351
Date:30.12.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 29.08.2019 takes the place of the publication of the European patent application.
[2020/53]
Search report(s)International search report - published on:US29.08.2019
(Supplementary) European search report - dispatched on:EP27.10.2021
ClassificationIPC:C12N9/10, C07K7/64, A61K35/12, A61K38/45, A61K47/60, A61K47/64
[2021/47]
CPC:
C07K7/64 (EP,US); C12N9/1077 (EP,US); A61K35/12 (EP);
A61K38/45 (EP,US); A61K47/60 (EP,US); A61K47/645 (EP);
C12Y204/02004 (EP,US); A01K2217/075 (EP); A01K2227/105 (EP);
A01K2267/0306 (EP); C07K2319/00 (US); C07K2319/10 (EP);
C07K2319/30 (EP) (-)
Former IPC [2021/01]A61K35/28, A61K48/00, C12N5/078
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/01]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON MITOCHONDRIALER NEUROGASTROINTESTINALER ENZEPHALOPATHIE[2021/01]
English:COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY[2021/01]
French:COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE L'ENCÉPHALOPATHIE MITOCHONDRIALE NEUROGASTRO-INTESTINALE[2021/01]
Entry into regional phase18.09.2020National basic fee paid 
18.09.2020Search fee paid 
18.09.2020Designation fee(s) paid 
18.09.2020Examination fee paid 
Examination procedure18.09.2020Examination requested  [2020/53]
22.06.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
25.07.2022Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
25.07.2022Request for further processing filed
25.07.2022Full payment received (date of receipt of payment)
Request granted
03.08.2022Decision despatched
Fees paidRenewal fee
12.02.2021Renewal fee patent year 03
14.01.2022Renewal fee patent year 04
15.02.2023Renewal fee patent year 05
24.02.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2015179691  (OHIO STATE INNOVATION FOUNDATION [US]) [Y] 1-15* the whole document *;
 [Y]US2018030411  (KAHVEJIAN AVAK [US], et al) [Y] 1-15 * paragraph [0659]; example 81; table 8 *
International search[A]US2014235557  (DE WAARD MICHEL [FR]) [A] 1-4, 5/2-4, 6/5/2-4, 7/5/2-4, 8/5/2-4, 9/5/2-4* ; entire document *;
 [A]US2017020926  (MATA-FINK JORDI [US], et al) [A] 1-4, 5/2-4, 6/5/2-4, 7/5/2-4, 8/5/2-4, 9/5/2-4 * ; entire document *;
 [X]US2018030411  (KAHVEJIAN AVAK [US], et al) [X] 1-4, 5/2-4, 6/5/2-4, 7/5/2-4, 8/5/2-4, 9/5/2-4 * ; paragraphs [0611], [0630], [0659] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.